163 related articles for article (PubMed ID: 14606621)
1. Citrobacter bacteremia in a tertiary care hospital.
Gupta N; Yadav A; Choudhary U; Arora DR
Scand J Infect Dis; 2003; 35(10):765-8. PubMed ID: 14606621
[TBL] [Abstract][Full Text] [Related]
2. Citrobacter freundii bacteremia: Risk factors of mortality and prevalence of resistance genes.
Liu LH; Wang NY; Wu AY; Lin CC; Lee CM; Liu CP
J Microbiol Immunol Infect; 2018 Aug; 51(4):565-572. PubMed ID: 28711438
[TBL] [Abstract][Full Text] [Related]
3. Resistance to extended-spectrum cephalosporins and mortality in patients with Citrobacter freundii bacteremia.
Kim BN; Woo JH; Ryu J; Kim YS
Infection; 2003 Aug; 31(4):202-7. PubMed ID: 14562942
[TBL] [Abstract][Full Text] [Related]
4. Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome.
Drelichman V; Band JD
Arch Intern Med; 1985 Oct; 145(10):1808-10. PubMed ID: 3899035
[TBL] [Abstract][Full Text] [Related]
5. Review of Citrobacter bacteremia in cancer patients over a sixteen-year period.
Samonis G; Anaissie E; Elting L; Bodey GP
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):479-85. PubMed ID: 1915382
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic sensitivity pattern of Citrobacter isolated from various clinical specimens in a tertiary care hospital.
Shetty J; Kotigadde S
Indian J Pathol Microbiol; 2007 Jul; 50(3):666-8. PubMed ID: 17883179
[TBL] [Abstract][Full Text] [Related]
7. Bacteremia due to Citrobacter species: significance of primary intraabdominal infection.
Shih CC; Chen YC; Chang SC; Luh KT; Hsieh WC
Clin Infect Dis; 1996 Sep; 23(3):543-9. PubMed ID: 8879778
[TBL] [Abstract][Full Text] [Related]
8. Anti-microbial resistance profile of Citrobacter species in a tertiary care hospital of Southern India.
Metri BC; Jyothi P; Peerapur BV
Indian J Med Sci; 2011 Oct; 65(10):429-35. PubMed ID: 23511043
[TBL] [Abstract][Full Text] [Related]
9. Citrobacter infections in a tertiary care hospital in Northern India.
Mohanty S; Singhal R; Sood S; Dhawan B; Kapil A; Das BK
J Infect; 2007 Jan; 54(1):58-64. PubMed ID: 16815552
[TBL] [Abstract][Full Text] [Related]
10. Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital.
Choi HK; Kim YK; Kim HY; Park JE; Uh Y
Korean J Intern Med; 2015 Mar; 30(2):219-25. PubMed ID: 25750564
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and antimicrobial susceptibility trends in Citrobacter freundii bacteremia.
Chen YS; Wong WW; Fung CP; Yu KW; Liu CY
J Microbiol Immunol Infect; 2002 Jun; 35(2):109-14. PubMed ID: 12099331
[TBL] [Abstract][Full Text] [Related]
12. Epidemic infection caused by Citrobacter rodentium in a gerbil colony.
de la Puente-Redondo VA; Gutiérrez-Martín CB; Pérez-Martínez C; del Blanco NG; García-Iglesias MJ; Pérez-García CC; Rodríguez-Ferri EF
Vet Rec; 1999 Oct; 145(14):400-3. PubMed ID: 10574274
[TBL] [Abstract][Full Text] [Related]
13. Bacteraemia caused by non-freundii, non-koseri Citrobacter species in Taiwan.
Lai CC; Tan CK; Lin SH; Liu WL; Liao CH; Huang YT; Hsueh PR
J Hosp Infect; 2010 Dec; 76(4):332-5. PubMed ID: 20708303
[TBL] [Abstract][Full Text] [Related]
14. Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species.
Kim BN; Lee SO; Choi SH; Kim NJ; Woo JH; Ryu J; Kim YS
Int J Antimicrob Agents; 2003 Aug; 22(2):106-11. PubMed ID: 12927949
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia due to Citrobacter braakii: A case report and literature review.
Hirai J; Uechi K; Hagihara M; Sakanashi D; Kinjo T; Haranaga S; Fujita J
J Infect Chemother; 2016 Dec; 22(12):819-821. PubMed ID: 27553069
[TBL] [Abstract][Full Text] [Related]
16. Observations on Citrobacter species from a tertiary care health center with special reference to multi-drug resistance and presence of CTX-M gene.
Mohan S; Agarwal J; Srivastava R; Singh M
Indian J Pathol Microbiol; 2014; 57(3):439-41. PubMed ID: 25118739
[TBL] [Abstract][Full Text] [Related]
17. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
18. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
19. Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism.
Khorasani G; Salehifar E; Eslami G
Burns; 2008 Nov; 34(7):947-52. PubMed ID: 18378087
[TBL] [Abstract][Full Text] [Related]
20. Cefotaxime-resistant Citrobacter freundii in isolates from blood in a tertiary teaching hospital in Northern Taiwan.
Liu CP; Weng LC; Tseng HK; Wang NY; Lee CM
J Infect; 2007 Oct; 55(4):363-8. PubMed ID: 17572502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
